Zhang et al. Stem Cell Research & Therapy (2022) 13:70 https://doi.org/10.1186/s13287-022-02745-y REVIEW | Open Access Application of stem cells in the repair of intervertebral disc degeneration Wentao Zhang1† | Tianze Sun1† | Ying Li4,5 | Ming Yang1 | Yantao Zhao3 | Jing Liu4,5 | Zhonghai Li1,2,4,5*

Ứng dụng tế bào gốc trong điều trị đĩa đệm bị thoái hóa (intervertebral disk degeneration) Stem Cells and Intervertebral Disc Regeneration Overview—What They Can and Can't Do - PMC (nih.gov) (2021) Application of stem cells in the repair of intervertebral disc degeneration | Stem Cell Research & Therapy | Full Text (biomedcentral.com) (2022)

Guo et al. Cell Death and Disease (2020) 11:349 https://doi.org/10.1038/s41419-020-2542-9 Cell Death & Disease REVIEW ARTICLE | Open Access The therapeutic potential of mesenchymal stem cells for cardiovascular diseases Yajun Guo1,2 | Yunsheng Yu1,2 | Shijun Hu1,2,3,4 | Yueqiu Chen1,2 | Zhenya Shen1,2

Attar et al. Stem Cell Research & Therapy (2021) 12:600 https://doi.org/10.1186/s13287-021-02667-1 RESEARCH | Open Access Mesenchymal stem cell transplantation after acute myocardial infarction: a meta-analysis of clinical trials Armin Attar1* | Fateme Bahmanzadegan Jahromi2 | Shahin Kavousi2 | Ahmad Monabati3,4 | Asma Kazemi5*

REVIEW published: 12 January 2022 doi: 10.3389/fcell.2021.742088 Mesenchymal Stem Cell Immunomodulation: A Novel Intervention Mechanism in Cardiovascular Disease Yueyao Wang1,2† | Zhongwen Qi 3† | Zhipeng Yan1 | Nan Ji 1 | Xiaoya Yang1 | Dongjie Gao1 | Leilei Hu1 | Hao Lv 1 | Junping Zhang1* | Meng Li 1

Cardiovascular Drugs and Therapy (2018) 32:329–338 https://doi.org/10.1007/s10557-018-6804-z ORIGINAL ARTICLE Improvement in Left Ventricular Function with Intracoronary Mesenchymal Stem Cell Therapy in a Patient with Anterior Wall ST-Segment Elevation Myocardial Infarction Su Hyun Kim1 & Jang Hyun Cho1 & Yoon Ho Lee 2 & Ji Hye Lee2 & Soo Sung Kim2 & Mi Yang Kim2 & Min Gu Lee1 & Won Yu Kang1 & Kyung Sim Lee3 & Young Keun Ahn4 & Myung Ho Jeong4 & Hyun Soo Kim5 Published online: 28 June 2018 © The Author(s) 2018

European Heart Journal (2016) 37, 256–263 doi:10.1093/eurheartj/ehv493 CLINICAL RESEARCH Acute coronary syndromes A randomized double-blind control study of early intra-coronary autologous bone marrow cell infusion in acute myocardial infarction: the REGENERATE-AMI clinical trial† Fizzah Choudry1‡, Stephen Hamshere1‡, Natalie Saunders2, Jessry Veerapen1, Katrine Bavnbek3, Charles Knight1, Denis Pellerin3, Didier Locca4, Mark Westwood1, Roby Rakhit5, Tom Crake3, Jens Kastrup6, Mahesh Parmar7, Samir Agrawal2, Daniel Jones1, John Martin8, and Anthony Mathur1,9*

Tiềm năng của tế bào gốc trung mô trong điều trị bệnh lý tim mạch The therapeutic potential of mesenchymal stem cells for cardiovascular diseases (2020) Mesenchymal Stem Cell Immunomodulation: A Novel Intervention Mechanism in Cardiovascular Disease (2021) Mesenchymal stem cell transplantation after acute myocardial infarction: a meta-analysis of clinical trials (2021)

Received: 14 December 2019 | Accepted: 8 April 2020 DOI: 10.1002/sctm.19-0434 HUMAN CLINICAL ARTICLE Infusion of human umbilical cord tissue mesenchymal stromal cells in children with autism spectrum disorder Jessica M. Sun1 | Geraldine Dawson2 | Lauren Franz2 | Jill Howard2 | Colleen McLaughlin1 | Bethany Kistler1 | Barbara Waters-Pick3 | Norin Meadows1 | Jesse Troy1 | Joanne Kurtzberg1  

Submit a Manuscript: https://www.f6publishing.com | World J Stem Cells 2019 February 26; 11(2): 55-72 DOI: 10.4252/wjsc.v11.i2.55 | ISSN 1948-0210 (online) REVIEW Rational use of mesenchymal stem cells in the treatment of autism spectrum disorders Qiang Liu, Mo-Xian Chen, Lin Sun, Chloe U Wallis, Jian-Song Zhou, Li-Juan Ao, Qi Li, Pak C Sham